Related Experiment Video
Updated: May 7, 2025

08:00
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
7.4K
Functional specialization of MITF, TFEB and TFE3 drives radically distinct adaptive gene expression programs in
Biorxiv : the Preprint Server for Biology
|January 7, 2025
Summary
Three related transcription factors (MITF, TFE3, and TFEB) in melanoma exhibit specialized roles, driving distinct gene programs that impact cancer progression and phenotypic changes in response to cellular stress.
Area of Science:
- Cellular biology
- Molecular oncology
- Gene regulation
Background:
- Multiple transcription factors can target the same DNA sequences, leading to complex regulatory outcomes.
- The distinct biological functions of co-targeting transcription factors remain largely uncharacterized.
- In melanoma, MITF, TFEB, and TFE3 are co-expressed and regulate key cellular processes.
Purpose of the Study:
- To elucidate the functional specialization of MITF, TFEB, and TFE3 in melanoma.
- To understand the impact of these co-targeting transcription factors on cancer progression.
- To investigate how these factors coordinate gene expression programs under varying cellular conditions.
Main Methods:
- Analysis of gene expression programs regulated by MITF, TFEB, and TFE3.
- Investigation of transcription factor binding to shared DNA sequences.
- Assessment of the role of these factors in response to microenvironmental cues like glucose limitation.
Main Results:
- MITF, TFEB, and TFE3, despite binding similar sequences, regulate distinct and often opposing gene expression programs.
- These factors coordinate cellular differentiation, metabolic reprogramming, protein synthesis, and immune modulator expression.
- A hierarchical cascade is revealed where environmental stresses trigger these factors to drive specific transcriptional programs.
Conclusions:
- Functional specialization of MITF, TFEB, and TFE3 is critical for coordinating diverse cellular processes in melanoma.
- These transcription factors play key roles in mediating phenotypic transitions in cancer.
- Understanding these distinct roles provides insights into melanoma progression and potential therapeutic strategies.
Related Concept Videos
Master Transcription Regulators
6.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.7K
General Transcription Factors
5.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.1K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Transcription Factors
75.3K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.3K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K

